December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Identification of a Novel Retinal Kinase with Promoter Elements Affected by Circadian Clock Proteins
Author Affiliations & Notes
  • SN Archer
    School of Biomedical & Life Sciences University of Surrey Guildford United Kingdom
  • RJ Lucas
    Department of Integrative & Molecular Neuroscience Imperial College Medical School London United Kingdom
  • S Thompson
    Department of Integrative & Molecular Neuroscience Imperial College Medical School London United Kingdom
  • RG Foster
    Department of Integrative & Molecular Neuroscience Imperial College Medical School London United Kingdom
  • M von Schantz
    School of Biomedical & Life Sciences University of Surrey Guildford United Kingdom
  • Footnotes
    Commercial Relationships   S.N. Archer, None; R.J. Lucas, None; S. Thompson, None; R.G. Foster, None; M. von Schantz, None. Grant Identification: BBSRC 90/S10156
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1371. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      SN Archer, RJ Lucas, S Thompson, RG Foster, M von Schantz; Identification of a Novel Retinal Kinase with Promoter Elements Affected by Circadian Clock Proteins . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1371.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We have studied gene expression differences between wildtype and rd mouse retinae to identify genes that may be associated with the retinal circadian clock. The perturbation of the circadian clock in the rd retina may be associated with decreased expression of specific genes. Methods: Wildtype and rd radiolabelled cDNA probes were reverse transcribed from mRNA pooled from circadian time (ZT) 0, 4, 8, 12, 16, 20 and used to screen pairs of human and mouse macroarrays (GDA, Incyte). Differential positives were confirmed with slot blot and northern hybridisation. The identity and human chromosomal localisation of one candidate positive was determined by BLAST search. Genomic DNA flanking the gene was analysed for conserved promoter motifs. Potential promoter fragments were amplified and inserted into luciferase reporter constructs, cotransfected into COS cells with combinations of known circadian transcription factors, and detected with a dual-luciferase assay kit. Results: BLAST search identified the candidate as the mouse embryo development protein kinase (EDPK) or human Krct, novel serine/threonine orthologs with unknown function. Krct localised to human chromosome 2 immediately flanking serine threonine kinase 16 (STK16). The upstream DNA contains two highly similar sequences that show conservation with an opsin promoter, sections of the mouse Period gene promoter and the Drosophila circadian regulatory sequence (CRS). The sequences also contain conserved E-box, Crx, and E-opsin/MASH motifs. Each promoter sequence showed orientation-specific enhancement of luciferase activity. One sequence is unaffected by the circadian transcription factors CLOCK and BMAL1 but enhanced by PER1 and PER2 while the other appears to be enhanced by CLOCK. Conclusion: Mouse EDPK / human Krct is a novel kinase with unknown function in the retina. It maps adjacent to another serine/threonine kinase on human chromosome 2. Flanking regions show conservation with known retinal/circadian promoter elements and two sections of the promoter region exhibit differential responses to known circadian transcription factors. Current experiments are localising the in-situ expression of this gene in the retina to help further characterise its function.

Keywords: 417 gene/expression • 556 retina: neurochemistry • 525 protein modifications-post translational 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×